Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Peking University
Merck Sharp & Dohme LLC
Incyte Corporation
Verastem, Inc.
AstraZeneca
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Daiichi Sankyo
Verastem, Inc.
Trishula Therapeutics, Inc.
Hummingbird Bioscience
Theriva Biologics SL